Summit Research Network Oregon Inc.

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials
• Type 2 diabetes1 trial

Phase

• Phase 34 trials

Status

• Completed3 trials
• Suspended1 trial

Lead sponsor

• Novo Nordisk A/S3 trials
• Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 trial

Closed trials

• Completed

  A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise

  NCT06323174· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· Phase 3· Novo Nordisk A/S· Source